The earnings call highlighted strong financial growth and successful strategic acquisitions, notably the Gentiva acquisition, which expanded market reach. However, there are concerns regarding potential Medicaid funding changes and operational challenges related to weather and seasonal factors. Despite some challenges, the company's strategic positioning and financial health appear robust.
Company Guidance
During Addus HomeCare's fourth quarter 2024 earnings call, the company provided several financial metrics and guidance. Total revenue for the quarter increased by 7.5% to $297.1 million compared to the same quarter in 2023. Adjusted earnings per share rose by 4.6% to $1.38, while adjusted EBITDA increased by 10.3% to $37.8 million. For the full year 2024, Addus reported a 9.1% revenue increase to $1.2 billion, with adjusted earnings per share up by 14.9% to $5.26, and adjusted EBITDA up by 15.9% to $140.3 million. The company ended the year with approximately $100 million in cash on hand and a conservative leverage position of just under one times adjusted EBITDA. Addus also highlighted the successful integration of its largest acquisition to date, Gentiva Personal Care, which contributed to the revenue growth. The company expects the Illinois rate increase effective January 1, 2025, to contribute approximately $23 million in annualized revenue with a margin in the low 20% range. Looking ahead, Addus anticipates maintaining its targeted minimum annual revenue growth of 10%, supported by strategic acquisitions and favorable reimbursement support for personal care services.
Revenue Growth
Total revenue for Q4 2024 was $297.1 million, an increase of 7.5% compared to Q4 2023. For the full year 2024, total revenue was $1.2 billion, an increase of 9.1% compared to 2023.
Adjusted Earnings and EBITDA Increase
Adjusted earnings per share for Q4 2024 was $1.38, a 4.6% increase from Q4 2023. Adjusted EBITDA for Q4 was $37.8 million, a 10.3% increase from Q4 2023.
Successful Acquisition of Gentiva
Addus completed its largest acquisition to date with Gentiva, adding approximately $280 million in annualized revenues and significantly expanding market coverage.
Strong Cash Flow
Consistent cash flow with $100 million on hand at the end of 2024 and a conservative leverage position under one times Adjusted EBITDA.
---
Addus Homecare (DE:A41) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
DE:A41 Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 24, 2025
€101.00
€102.00
+0.99%
Nov 04, 2024
€114.00
€108.00
-5.26%
Aug 05, 2024
€106.00
€106.00
0.00%
May 06, 2024
€89.50
€89.50
0.00%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Addus Homecare (DE:A41) report earnings?
Addus Homecare (DE:A41) is schdueled to report earning on May 05, 2025, TBA Not Confirmed.
What is Addus Homecare (DE:A41) earnings time?
Addus Homecare (DE:A41) earnings time is at May 05, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.